Cargando…

Risk for multidrug-resistant tuberculosis in patients treated with anti-tumor necrosis factor agents

BACKGROUND: There are few studies on medical conditions associated with the development of drug-resistant TB. OBJECTIVE: We investigated the risk factors for the occurrence of multidrug-resistant (MDR) tuberculosis (TB) in patients with pulmonary TB. MATERIALS AND METHODS: Based on claims data from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jinkyeong, Hong, Yoonki, Hong, Ji Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073508/ https://www.ncbi.nlm.nih.gov/pubmed/37035321 http://dx.doi.org/10.3389/fmed.2023.1108119

Ejemplares similares

Differences in ICU Outcomes According to the Type of Anticancer Drug in Lung Cancer Patients
por: Hong, Yoonki, et al.
Publicado: (2022)

Gender Differences in Antitussive Prescriptions for Chronic Cough in Korea
por: Park, Jinkyeong, et al.
Publicado: (2023)

The Role of Transbronchial Lung Biopsy in Diagnosing Pulmonary Mucormycosis in a Critical Care Unit
por: Hong, Yoonki, et al.
Publicado: (2017)

Clinical outcomes in patients with lung cancer admitted to intensive care units
por: Park, Jinkyeong, et al.
Publicado: (2021)

Association between the Respiratory Microbiome and Plasma Microbial Extracellular Vesicles in Intubated Patients
por: Park, Jinkyeong, et al.
Publicado: (2023)

Fistulized multidrug-resistant tuberculosis
por: El Omri, Naoual, et al.
Publicado: (2017)

A Comprehensive Analysis of 5-Year Outcomes in Patients with Cancer Admitted to Intensive Care Units
por: Hong, Yoonki, et al.
Publicado: (2022)

Metagenomic Analysis of Plasma Microbial Extracellular Vesicles in Patients Receiving Mechanical Ventilation: A Pilot Study
por: Park, Jinkyeong, et al.
Publicado: (2022)

The Influence of Asian Dust, Haze, Mist, and Fog on Hospital Visits for Airway Diseases
por: Park, Jinkyeong, et al.
Publicado: (2015)

Risk factors for latent tuberculosis infection in RA patients treated with anti-tumor necrosis factor
por: Huang, Shiang-Fen, et al.
Publicado: (2012)

Circumvention of Atypical Multidrug Resistance with Tumor Necrosis Factor
por: Cimoli, Guido, et al.
Publicado: (1994)

Cost-Effectiveness of Treating Multidrug-Resistant Tuberculosis
por: Resch, Stephen C, et al.
Publicado: (2006)

Mortality in patients with rheumatoid arthritis-associated interstitial lung disease treated with an anti-tumor necrosis factor agent
por: Koo, Bon San, et al.
Publicado: (2015)

Efficacy of iron supplementation in patients with inflammatory bowel disease treated with anti-tumor necrosis factor-alpha agents
por: Kim, Su Young, et al.
Publicado: (2020)

A Case of Multidrug-Resistant (MDR) Tuberculosis and HIV Co-Infection
por: Vila Torres, Sebastian G, et al.
Publicado: (2023)

Diagnosis and treatment of multidrug-resistant tuberculosis
por: Jang, Jong Geol, et al.
Publicado: (2020)

The impact of smoking status on radiographic progression in patients with ankylosing spondylitis on anti-tumor necrosis factor treatment
por: Nam, Bora, et al.
Publicado: (2022)

Active Tuberculosis Incidence and Characteristics in Patients Treated with Tumor Necrosis Factor Antagonists According to Latent Tuberculosis Infection
por: Lee, Eun Hye, et al.
Publicado: (2017)

Immunomodulatory Agents Combat Multidrug-Resistant Tuberculosis by Improving Antimicrobial Immunity
por: Rao Muvva, Jagadeeswara, et al.
Publicado: (2021)

Novel oxazolidinones harbor potent in vitro activity against the clinical isolates of multidrug-resistant Mycobacterium tuberculosis in China
por: Wang, Chenqian, et al.
Publicado: (2022)

Multidrug-resistant tuberculosis
por: Zager, Ellen M, et al.
Publicado: (2008)

Multidrug-resistant tuberculosis
por: Lemos, Antônio Carlos Moreira, et al.
Publicado: (2013)

New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline
por: Leibert, Eric, et al.
Publicado: (2014)

1881. Costs of Treating Multidrug Resistant Tuberculosis in California, 2022
por: Katrak, Shereen, et al.
Publicado: (2023)

Prevalence of Multidrug-Resistant Tuberculosis in HIV/Tuberculosis Co-Infected Patients
por: Lee, Chan Mi, et al.
Publicado: (2021)

Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease
por: Marsal, Jan, et al.
Publicado: (2022)

Prior treated tuberculosis and mortality risk in lung cancer
por: Liao, Kuang-Ming, et al.
Publicado: (2023)

Primary Disseminated Multidrug-Resistant Tuberculosis of the Lungs, Brain, Meninges, and Abdomen: The World’s First Case
por: Yadav, Sankalp
Publicado: (2023)

Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis
por: Zumla, Alimuddin, et al.
Publicado: (2016)

Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
por: Park, Jihye, et al.
Publicado: (2021)

Effectiveness of a novel cellular therapy to treat multidrug-resistant tuberculosis
por: Skrahin, Aliaksandr, et al.
Publicado: (2016)

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2018)

Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives
por: Pontali, Emanuele, et al.
Publicado: (2019)

Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia
por: Desissa, Fanta, et al.
Publicado: (2018)

Predictors of Treatment Success for Multidrug Resistant Tuberculosis
por: Park, Sang Won
Publicado: (2016)

Frequency of Positive Conversion of Interferon-Gamma Release Assay Results Among Patients With Inflammatory Bowel Disease Treated With Non-tumor Necrosis Factor Inhibitors
por: Kim, Kyuwon, et al.
Publicado: (2021)

Pharmacotherapy for multidrug resistant tuberculosis
por: Chhabra, Naveen, et al.
Publicado: (2012)

The Threat of Multidrug-resistant Tuberculosis
por: Paul, Rudrajit
Publicado: (2018)

Paradoxical Arthralgia Secondary to Anti-Tumor-Necrosis-Factor Alpha Therapy in Crohn’s Disease
por: Thurlapati, Aswani, et al.
Publicado: (2021)

Tuberculosis-Infected Giant Bulla Treated by Percutaneous Drainage Followed by Obliteration of the Pulmonary Cavity Using Talc: Case Report
por: Heo, Jeongwon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h89et2k03lcbnkldknbok6i30p